Effect of MD1003 (high dose pharmaceutical grade biotin) for the treatment of progressive MS: long-term safety data at 60 months of follow-up

Affiliation auteurs!!!! Error affiliation !!!!
TitreEffect of MD1003 (high dose pharmaceutical grade biotin) for the treatment of progressive MS: long-term safety data at 60 months of follow-up
Type de publicationJournal Article
Year of Publication2019
AuteursDe Seze J., Edan G., Moreau T., Sedel F., Tourbah A.
JournalMULTIPLE SCLEROSIS JOURNAL
Volume25
Pagination773-774
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN1352-4585